Mass Spec Predicts Improved Response to Anti-HER2 Therapy in Breast Cancer

News   Jul 07, 2014

 
Mass Spec Predicts Improved Response to Anti-HER2 Therapy in Breast Cancer
 
 
 

RELATED ARTICLES

Bacteria Produce More Substances Than Genetics Predicted

News

Tandem mass spectrometry has revealed that Streptomyces chartreusis, an antibiotic-producing bacterium, releases more metabolites into the surrounding medium than scientists assumed based on the analysis of the genome. They might include molecules that are of interest as potential pharmaceutical agents.

READ MORE

HIV Saliva Test Adapted for Rapid Zika Diagnosis

News

Researchers are developing a novel test for Zika virus that uses saliva to identify diagnostic markers of the virus in a fraction of the time of current commercial tests.

READ MORE

Investigational Drug for Melanoma Shows Promise in Early-Stage Study

News

An investigational compound designed to block a hyperactive cell growth signal in advanced melanoma and other cancers has shown some promise in an early-stage clinical trial researchers have reported.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE